Abstract OBJECTIVE: To study the effect and safety of aripiprazole in the treatment of childhood autism. METHODS: Thirty-five children (aged from 4 to 16 years) with autism presenting as behavioral disorders were treated with aripiprazole for 8 weeks. They were evaluated according to the Clinical Global Impression (CGI) and the Autism Treatment Evaluation Checklist (ATEC) before treatment and at the end of the 2nd, 4th and 8th weeks of treatment. Adverse reactions were observed. RESULTS: The CGI showed illness severity decreased from the second week of aripiprazole treatment (P<0.05) and more significantly decreased illness severity was observed at the end of the 8th week (P<0.01). The curative effect score significantly increased at the end of the 8th week (P<0.05). The ATEC total scores were significantly reduced at the end of the 8th week after aripiprazole treatment. Besides the social intercourse ability, great improvements were shown in verbal communication, apperception and behavioural symptoms after aripiprazole treatment (P<0.01). Self-harm, sleep disorders and psychiatric symptoms were greatly improved after treatment and attention deficit, excessive activities, impulse to attack behavior, stereotyped behaviors and irritability were also improved to some extent. No severe adverse effects were found. CONCLUSIONS: Aripiprazole is safe and effective for the treatment of childhood autism.
［7］McCracken JT, McGough J, Shah B, Cronin P, Hong D, AmanMG, et al. Risperidone in children with autism and serious behav-ioral problems［J］. N Engl J Med, 2002, 347(5): 314-321.
［8］Fombonne E. Risperidone improves restricted, repetitive, and stereotyped behaviour in autistic children and adolescents［J］. Evid Based Ment Health, 2006, 9(1): 6.
［9］Valicenti M, cDermott MR, Demb HM. Clinical effects and adverse reactions of off-label use of aripiprazole in childrenand adolescents with developmental disabilities［J］. J Child Adolesc Psychopharmacol, 2006, 16 (5): 49-56.
［10］Marcus RN, Owen R, Kamen L, Manos G, McQuade RD, Carson WH, et al. A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder［J］. J Am Acad Child Adolesc Psychiatry, 2009, 48 (11): 1110-1119.
［11］Owen R, Sikich L, Marcus RN, Corey-Lisle P, Manos G, McQuade RD, et al. Aripiprazole in the treatment of irirritability in children and adolescents with autistic disorder［J］. Pediatrics, 2009, 124(6): 1533-1540.
